Evidence-Based Treatment Ladder for Chronic Prostatitis/Chronic Pelvic Pain

Area of Science:

• Urology
• Andrology
• Pharmacology

Background:

• Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) affects 2%-10% of men globally.
• Standardized treatment algorithms for CP/CPPS are lacking.
• This study addresses the need for a definitive treatment hierarchy.

Purpose of the Study:

• To establish an evidence-based treatment hierarchy for CP/CPPS.
• To compare the efficacy of alpha-blocker monotherapy, alpha-blocker plus antibiotic, alpha-blocker plus saw palmetto, and TUR surgery.
• To evaluate safety profiles and histopathological findings.

Main Methods:

• Retrospective comparative cohort study of 200 adult males with CP/CPPS.
• Patients were divided into four treatment groups (50 per group).
• NIH-CPSI scores were used to assess primary endpoint (12-week improvement) and clinical response (≥6-point improvement).

Main Results:

• TUR surgery showed the highest efficacy (88% clinical response, 15.7-point NIH-CPSI improvement).
• Alpha-blocker plus saw palmetto combination was the most effective medical therapy (80% response, 10.7-point improvement).
• Alpha-blocker plus antibiotic combination offered no advantage over monotherapy; prostatic stones were found in 76% of TUR specimens.

Conclusions:

• TUR surgery is the most effective treatment for refractory CP/CPPS.
• Alpha-blocker plus saw palmetto combination represents optimal medical therapy.
• Antibiotic use is not beneficial for non-bacterial prostatitis, supporting antibiotic stewardship.